- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 22, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article published in the March 2016 issue of The American Journal of Managed Care® (AJMC®) was cited in 2 pieces online this week. Yahoo! published “Are Your Hospital Outpatient Department Costs Too High? A Doctor's Office May Help” and Healthcare Finance published “Costs for Common Healthcare Procedures Higher in Hospital Outpatient Departments,” both referencing the findings in “National Estimates of Price Variation by Site of Care” that prices for services performed at hospital outpatient departments were higher than in physician offices.
The National Pharmaceutical Council’s CER Daily Newsfeed for September 19, 2023, highlighted a video interview published on AJMC.com, the website of AJMC. “Dr Ryan Haumschild Discusses Payer, Provider Perspectives on Prior Authorization in Rare Diseases” featured AJMC editorial board member Ryan Haumschild, PharmD, MS, MBA, director of pharmacy at Emory Winship Cancer Institute, sharing his unique perspectives as both a provider and payer on the use of prior authorizations.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
